The Recall Desk
Agency classClass IIOur severity:ModerateFDA (Drugs)·D-1520-2016·Announced 2016-10-05

Pharmatech Recalls Sennazon Syrup Due to Potential B. cepacia Contamination

Pharmatech LLC is recalling 1,008 bottles of Sennazon (sennosides) Syrup nationwide due to a potential risk of contamination with B. cepacia bacteria.

The agency’s classification

FDA (Drugs): Class II

Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.

This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work

What this means for you

Our assessment, not the agency’s: severity 2/5 (Moderate).

Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.

Our severity reasoning: The recall is classified as FDA Class II and is described as a precautionary measure due to a potential risk of contamination, fitting the criteria for moderate severity involving low-risk contamination or voluntary precautionary actions without reported illness.

Plain-English summary

Pharmatech LLC is recalling 1,008 bottles of Sennazon (sennosides) Syrup, 8.8 mg, 8 fl. oz. (237 mL) bottles. The product is manufactured for Bayshore Pharmaceuticals and carries the NDC 76518-100-08. The specific lot number is 20391519, with an expiration date of 11/17.

The recall was initiated as a precautionary measure due to Current Good Manufacturing Practice (CGMP) deviations. These deviations created a potential risk of product contamination with the bacteria B. cepacia. The affected product was distributed nationwide.

Consumers who have this product should stop using it and contact Pharmatech LLC or their healthcare provider for instructions on how to return or dispose of the medication.

The recalled product

Product
Sennazon (sennosides) Syrup, 8.8 mg, 8 fl. oz. (237 mL) bottle, Mfd. for: Bayshore Pharmaceuticals, Tampla, FL 33619, NDC 76518-100-08.
Manufacturer
Pharmatech LLC
Affected units
1,008

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (2)

  • Lot #: 20391519
  • Exp 11/17

Distribution

Distributed nationwide across the United States.

Part of a larger recall action

This product is one of 7 recalled by Pharmatech LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.

See all 7 products in this recall →

Similar recalls